A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure

Summary

The purpose of the study is to gather information regarding the safety and effectiveness of an investigational drug called Alagebrium when used treating Heart Failure in relation to exercise tolerance after 6 months in the trial.

Timeline

Start

2007-12

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped (Business): “Sponsor lost funding”

Drugs

Indications